Fig. 1From: Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomesComparison of chemokine score with (a) molecular subtype and (b) immunohistochemistry (IHC). ER estrogen receptor, HER2 human epidermal growth factor receptor 2, TNBC triple-negative breast cancerBack to article page